{'fraction_non_alphanumeric': 0.025078369905956112, 'fraction_numerical': 0.014106583072100314, 'mean_word_length': 5.726315789473684, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Utility of Vasopressin Rescue Therapy in Neonates with Persistent Pulmonary Hypertension of the Newborn

Background: Persistent pulmonary hypertension of newborn (PPHN) affects 1.9 per 1000 live births and has a varied mortality ranging between 4-33%. Although inhaled nitric oxide (iNO) has reduced the need for Extracorporeal membrane oxygenation (ECMO) in this population, refractory cases persist. Vasopressin is gaining favor as a treatment modality in neonates despite limited data and concerns for hyponatremia and decreased intestinal perfusion. Objective: To describe the effect of vasopressin on oxygenation and systemic blood …